Kidney Cancer: Expert Guidance for Adapting Novel Agents Into Practice
Kidney Cancer: Expert Guidance for Adapting Novel Agents Into Practice is organized by Prime Education, LLC.
Release Date: November 15, 2023
Expiration Date: November 14, 2024
Description:
As the therapeutic landscape continues to evolve, clinicians face barriers to the integration of new clinical data into treatment plans for patients with advanced renal cell carcinoma (RCC). Optimal patient outcomes are impeded by barriers to timely treatment decision-making.
Tune in to this webcast, featuring a deep dive into the latest clinical data for new and emerging therapies in RCC and evidenced-based strategies for risk stratification and guideline-recommended treatment selection in federal, public, and government health care settings.
Learning Objectives:
• Design appropriate treatment strategies based on biomarker testing results and other patient- and disease-specific factors
• Differentiate novel therapies based on the latest clinical trial data and current guideline recommendations
• Identify adverse events associated with novel therapies and take steps to mitigate their effects